BioNxt Secures Innovative Chaperone Technology to Enhance Oral Thin-Film Drug Delivery

Core Viewpoint - BioNxt Solutions Inc. has signed a non-binding letter of intent to secure exclusive rights to advanced drug chaperone technology for oral dissolvable applications, which is expected to enhance its proprietary oral dissolvable thin-film platform significantly [1] Company Summary - BioNxt Solutions Inc. is a bioscience innovator specializing in advanced drug delivery systems [1] - The company aims to integrate variable-affinity drug chaperone technology from a third-party biotechnology developer focused on chaperone-enabled delivery systems [1]